Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 05 2022
Historique:
received: 14 01 2022
accepted: 19 04 2022
entrez: 25 5 2022
pubmed: 26 5 2022
medline: 28 5 2022
Statut: epublish

Résumé

Mouse models are commonly used to study the colonisation profiles of microorganisms introduced to the gastrointestinal tract. Three commonly used mouse models include conventional, germ-free, and antibiotic-treated mice. However, colonisation resistance in conventional mice and specialised equipment for germ-free mice are usually limiting factors in their applications. In this study, we sought to establish a robust colonisation model for Saccharomyces boulardii, a probiotic yeast that has caught attention in the field of probiotics and advanced microbiome therapeutics. We characterised the colonisation of S. boulardii in conventional mice and mice treated with a cocktail of broad-spectrum antibiotics, including ampicillin, kanamycin, metronidazole and vancomycin. We found colonisation levels increased up to 10,000-fold in the antibiotic-treated mice compared to nonantibiotic-treated mice. Furthermore, S. boulardii was detected continuously in more than 75% of mice for 10 days after the last administration in antibiotic-treated mice, in contrast to in nonantibiotic-treated mice where S. boulardii was undetectable in less than 2 days. Finally, we demonstrated that this antibiotic cocktail can be used in two commonly used mouse strains, C57BL/6 and ob/ob mice, both achieving ~ 10

Identifiants

pubmed: 35614092
doi: 10.1038/s41598-022-12806-0
pii: 10.1038/s41598-022-12806-0
pmc: PMC9133042
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8862

Subventions

Organisme : Marie Curie
ID : No 813781
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

BMC Microbiol. 2020 Nov 11;20(1):340
pubmed: 33176677
PLoS One. 2014 Nov 12;9(11):e112660
pubmed: 25391025
Nat Biotechnol. 2018 Oct;36(9):857-864
pubmed: 30102294
J Clin Pharmacol. 2018 Oct;58 Suppl 10:S164-S179
pubmed: 30248200
Infect Immun. 2009 Jul;77(7):2741-53
pubmed: 19380465
Front Cell Neurosci. 2021 Jul 15;15:698172
pubmed: 34335190
Therap Adv Gastroenterol. 2013 Jul;6(4):295-308
pubmed: 23814609
Diabetes. 2015 May;64(5):1794-803
pubmed: 25626737
Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
J Mol Med (Berl). 2020 Dec;98(12):1675-1687
pubmed: 33025105
Biopharm Drug Dispos. 1989 Jul-Aug;10(4):353-64
pubmed: 2758101
Adv Drug Deliv Rev. 2016 Oct 1;105(Pt A):44-54
pubmed: 27158095
Genome Med. 2018 Jan 29;10(1):6
pubmed: 29378630
Gastroenterology. 1993 Apr;104(4):1108-15
pubmed: 8462799
Sci Rep. 2017 Mar 23;7(1):371
pubmed: 28336969
Mol Ecol. 2010 Dec;19(24):5555-65
pubmed: 21050295
J Clin Invest. 2012 May;122(5):1717-25
pubmed: 22484814
Therap Adv Gastroenterol. 2012 Mar;5(2):111-25
pubmed: 22423260
Cell. 2015 Dec 3;163(6):1428-43
pubmed: 26638072
Appl Environ Microbiol. 2016 Apr 04;82(8):2280-2287
pubmed: 26850302
Pharm Res. 2014 Dec;31(12):3404-14
pubmed: 24928365
ACS Synth Biol. 2021 May 21;10(5):1039-1052
pubmed: 33843197
Front Microbiol. 2018 Aug 07;9:1619
pubmed: 30131772
Front Neurosci. 2011 Feb 23;5:10
pubmed: 21390289
PLoS One. 2016 Apr 11;11(4):e0153351
pubmed: 27064405
J Adv Vet Anim Res. 2019 Dec 14;7(1):103-114
pubmed: 32219116
Sci Transl Med. 2019 Jan 16;11(475):
pubmed: 30651324
EcoSal Plus. 2004 Dec;1(1):
pubmed: 26443354
Front Microbiol. 2018 Apr 13;9:723
pubmed: 29706942
Methods Mol Biol. 2006;313:107-20
pubmed: 16118429
Lab Anim (NY). 2021 Jul;50(7):185-195
pubmed: 34127866
Sci Rep. 2019 Jan 23;9(1):420
pubmed: 30674978
Infect Immun. 1996 Dec;64(12):5225-32
pubmed: 8945570
Lab Anim (NY). 2017 Mar 22;46(4):114-122
pubmed: 28328896
Front Physiol. 2018 Oct 31;9:1534
pubmed: 30429801
Sci Rep. 2021 Feb 2;11(1):2738
pubmed: 33531650
Microbiome. 2020 Mar 5;8(1):28
pubmed: 32138779
Cell Mol Immunol. 2016 Mar;13(2):251-62
pubmed: 25942514
mBio. 2014 Jun 10;5(3):e01011-14
pubmed: 24917595
Appl Environ Microbiol. 2007 Apr;73(8):2458-67
pubmed: 17293506
Trends Cancer. 2020 Mar;6(3):192-204
pubmed: 32101723
Microbiome. 2020 Sep 12;8(1):133
pubmed: 32919472
Lab Anim Res. 2017 Jun;33(2):119-123
pubmed: 28747977
Int J Obes Suppl. 2019 Apr;9(1):10-19
pubmed: 31391921
Nat Microbiol. 2017 Apr 25;2:17057
pubmed: 28440276
Front Behav Neurosci. 2010 Jun 14;4:29
pubmed: 20676234
Can J Microbiol. 2004 Aug;50(8):615-21
pubmed: 15467787
Biotechniques. 2011 May;50(5):325-8
pubmed: 21548894
PLoS Biol. 2016 Aug 19;14(8):e1002533
pubmed: 27541692
Inflamm Bowel Dis. 2013 Jan;19(1):185-93
pubmed: 22570250
Diabetes. 2014 Aug;63(8):2876-87
pubmed: 24677716
J Hered. 1950 Dec;41(12):317-8
pubmed: 14824537
Therap Adv Gastroenterol. 2020 Jul 29;13:1756284820934315
pubmed: 32774464
Sci Transl Med. 2020 Oct 28;12(567):
pubmed: 33115949
Nucleic Acids Res. 2001 Jan 1;29(1):181-4
pubmed: 11125085
PLoS Biol. 2020 Jul 14;18(7):e3000411
pubmed: 32663221
World J Gastroenterol. 2010 May 14;16(18):2202-22
pubmed: 20458757
Gastroenterology. 2006 Dec;131(6):1812-25
pubmed: 17087945
Aliment Pharmacol Ther. 2017 Aug;46(3):213-224
pubmed: 28612983
FEMS Microbiol Rev. 2016 Jan;40(1):117-32
pubmed: 26323480
Trends Biotechnol. 2019 Jan;37(1):100-115
pubmed: 30318171
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495
Infect Immun. 2015 May;83(5):1983-91
pubmed: 25733524

Auteurs

Karl Alex Hedin (KA)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.

Vanessa Emily Rees (VE)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.

Hongbin Zhang (H)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.

Vibeke Kruse (V)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.

Ruben Vazquez-Uribe (R)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark. ruvas@biosustain.dtu.dk.

Morten Otto Alexander Sommer (MOA)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark. msom@bio.dtu.dk.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH